BIOMEDICAL STATISTICAL CONSULTING

Serial Number 98285852
Registration 7518104
700

Registration Progress

Application Filed
Nov 27, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered
Sep 24, 2024

Trademark Image

BIOMEDICAL STATISTICAL CONSULTING

Basic Information

Serial Number
98285852
Registration Number
7518104
Filing Date
November 27, 2023
Registration Date
September 24, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 24, 2024
Registration
Registered
Classes
035 042 045

Rights Holder

BIOMEDICAL STATISTICAL CONSULTING IP LLC

16
Address
2400 MARKET STREET, SUITE 200
PHILADELPHIA, PA 19103

Ownership History

Biomedical Statistical Consulting, Inc.

Original Applicant
03
Philadelphia, PA

Biomedical Statistical Consulting, Inc.

Original Registrant
03
Philadelphia, PA

BIOMEDICAL STATISTICAL CONSULTING IP LLC

New Owner After Registration #1
16
PHILADELPHIA, PA

Legal Representation

Attorney
Melissa E. Scott

USPTO Deadlines

Next Deadline
1891 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-24)
Due Date
September 24, 2030
Grace Period Ends
March 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

21 events
Date Code Type Description Documents
Mar 12, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 24, 2024 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 24, 2024 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
Aug 19, 2024 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Aug 16, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 16, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 16, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 16, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 11, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 11, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 11, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 8, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 8, 2024 IUAA P USE AMENDMENT ACCEPTED Loading...
Jul 8, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 8, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 28, 2024 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Feb 28, 2024 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Feb 28, 2024 IUAF S USE AMENDMENT FILED Loading...
Jan 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 30, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Promoting public awareness of clinical trial results, namely, reporting and presentation of clinical trial results; Providing consulting services in the field of regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with the submission of clinical trial results for applications for new pharmaceuticals and medical devices with governmental regulatory bodies; Regulatory submission management, namely, responding to inquiries regarding clinical trials from governmental regulatory bodies; Customer services, namely, responding to participant inquiries regarding clinical trials
First Use Anywhere: Sep 21, 1988
First Use in Commerce: Mar 3, 1999
Class 042
Consulting services for others in the field of guidance on the design of clinical trials; Consulting services for others in the field of expert review of proposed clinical trial design; data analysis of clinical trial results and clinical trial application submissions for others
First Use Anywhere: Sep 21, 1988
First Use in Commerce: Mar 3, 1999
Class 045
Representation of clients in biomedical and pharmaceutical regulatory proceedings
First Use Anywhere: Sep 21, 1988
First Use in Commerce: Mar 3, 1999

Classification

International Classes
035 042 045

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
CONSULTING